Previous 10 | Next 10 |
Both opportunity and risk assessments can be drawn from looking at the price action in Perkinelmer (NYSE: PKI). This is a practice commonly referred to as reading the charts. The summary data for PKI below demonstrates this, and there are trading plans that help invest...
Quidel Corporation ([[QDEL]] -10.9%) has failed to meet the consensus revenue estimates in Q4 2020 despite the surging pandemic driving a ~80.6% YoY sequential growth in revenue from COVID-19 products.Today, the stock is leading a broader selloff among COVID-19 test makers after Evercore ISI ...
PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the 41 st Annual Cowen Health Care Conference on Monday, March 1, 2021 from 12:20 p.m. to 12:50 p.m. ET. Prahlad Singh, president an...
CANTON, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, an...
While vaccines are on the way and case numbers have started to move in the right direction, signaling the waning of the pandemic crisis, COVID-19 isn’t going anywhere. Unfortunately, it will be with us in some form for quite some time. While we can potentially get fatalities down to un...
Image source: The Motley Fool. PerkinElmer Inc (NYSE: PKI) Q4 2020 Earnings Call Feb 2, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: PerkinElmer Inc (PKI) Q4 2020 Earnings Call Transcript
PerkinElmer (NYSE: PKI) stock skyrocketed 48% in 2020 -- one of its best performances in years. The demand for COVID-19 testing was the primary factor behind that strong growth. Yet PerkinElmer hasn't received a lot of attention from investors seeking to profit from the surge in...
PerkinElmer, Inc. (PKI) Q4 2020 Earnings Conference Call February 2, 2021 5:00 PM ET Company Participants Bryan Kipp - Vice President-Investor Relations Prahlad Singh - President and Chief Executive Officer Jamey Mock - Senior Vice President and Chief Financial Officer Conference Call Partici...
The following slide deck was published by PerkinElmer, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: PerkinElmer, Inc. 2020 Q4 - Results - Earnings Call Presentation
PerkinElmer (PKI): Q4 Non-GAAP EPS of $3.96 beats by $0.95; GAAP EPS of $3.38 beats by $0.75.Revenue of $1.36B (+68.8% Y/Y) beats by $140M.Press Release For further details see: PerkinElmer EPS beats by $0.95, beats on revenue
News, Short Squeeze, Breakout and More Instantly...
Revenue of $675 million; (30)% reported growth; (27)% organic growth; 6% non-COVID organic growth GAAP EPS of $4.50; Adjusted EPS from continuing operations of $1.01 Updates full year 2023 guidance Authorizes new $600 million share repurchase program To begin tradi...
Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Trusted partner to pharma, government and diagnostics customers with complete, end-to-end solutions To begin trading as RVTY under new name on ...
2023-05-07 19:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...